Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Necrosis01:16

Necrosis

7.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.4K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.4K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.4K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.6K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes of Surgical Options for Base-of-Thumb Arthritis: A Systematic Review and Network Meta-Analysis.

The Journal of hand surgery·2026
Same author

The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathology.

Research square·2025
Same author

Paediatric and adolescent ovarian torsion: a eight-year retrospective cohort study and literature review.

Acta chirurgica Belgica·2025
Same author

Mental Health Experiences and Challenges Among Individuals with Myasthenia Gravis: Insights from Patient-Centered, Qualitative Analyses.

Advances in therapy·2025
Same author

Exacerbation and myasthenic crisis in generalized myasthenia gravis: real-world healthcare resource utilization and cost burden in the United States.

Current medical research and opinion·2025
Same author

Scrambler therapy for chemotherapy-induced peripheral neuropathy: A case report.

Palliative & supportive care·2025
Same journal

Medication Usage in Motor Neuron Disease and Spinal Muscular Atrophy: Insights from the Muscular Dystrophy Association Neuromuscular Observational Research Data Hub.

Journal of clinical neuromuscular disease·2026
Same journal

Severe Necrotizing Myositis With Anti-HMGCR and Anti-MDA5 Antibodies Without Cutaneous Involvement.

Journal of clinical neuromuscular disease·2026
Same journal

Diagnostic Nerve Ultrasound of Lateral Femoral Cutaneous Mononeuropathy With Focal Neural and Fascicular Enlargement.

Journal of clinical neuromuscular disease·2026
Same journal

Letter to the Editor: Utility of Smartwatches in Neuromuscular Disease: Current Use and Barriers to Adoption.

Journal of clinical neuromuscular disease·2026
Same journal

When Variants Collide: Mixed Clinical Presentation of Pharyngeal-Cervical-Brachial and Acute Motor Axonal Neuropathy Features in Guillain-Barré Syndrome.

Journal of clinical neuromuscular disease·2026
Same journal

Acute Motor Axonal Neuropathy in Biotinidase Deficiency Complicated by Dietary Restriction.

Journal of clinical neuromuscular disease·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

21.1K

Necrotizing myopathies: an update.

Colin Quinn1, Johnny S Salameh, Thomas Smith

  • 1Departments of *Neurology; †Pathology, University of Massachusetts Medical Center, Worcester, MA; and ‡Department of Neurology and Neurosciences, New Jersey Medical School, Newark, NJ.

Journal of Clinical Neuromuscular Disease
|February 20, 2015
PubMed
Summary
This summary is machine-generated.

Necrotizing myopathy involves muscle fiber death without significant inflammation. It is categorized as immune-mediated (IMNM) or nonimmune-mediated (NIMNM), with distinct causes and treatments.

More Related Videos

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.7K
Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
04:44

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury

Published on: November 1, 2024

1.0K

Related Experiment Videos

Last Updated: Apr 17, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

21.1K
Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.7K
Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
04:44

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury

Published on: November 1, 2024

1.0K

Area of Science:

  • Neurology
  • Pathology
  • Immunology

Background:

  • Necrotizing myopathy is characterized by muscle fiber necrosis without substantial inflammation.
  • It is broadly classified into immune-mediated (IMNM) and nonimmune-mediated (NIMNM) forms.
  • Both forms typically present with proximal muscle weakness.

Purpose of the Study:

  • To define necrotizing myopathy and differentiate between immune-mediated and nonimmune-mediated subtypes.
  • To outline the clinical associations, pathological findings, and treatment strategies for each subtype.

Main Methods:

  • Review of pathological features, including fiber necrosis and inflammatory infiltrates.
  • Analysis of clinical associations such as antibodies, diseases, and exposures.
  • Evaluation of immunohistochemical findings and treatment approaches.

Main Results:

  • IMNM is associated with anti-SRP antibodies, connective tissue diseases, cancer, statins, and viral infections.
  • NIMNM is linked to medications and toxic exposures.
  • Muscle biopsy shows predominant fiber necrosis with minimal inflammation; IMNM may show complement deposition and variable MHC class I expression, while NIMNM typically lacks immunohistochemical abnormalities.

Conclusions:

  • IMNM treatment involves immunosuppression, though specific protocols are not trial-guided.
  • NIMNM management requires removal of the causative agent.
  • Accurate classification is crucial for appropriate therapeutic strategies.